• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

2023 ESC Guidelines for the management of acute coronary syndromes Page 1 2023 ESC
Guidelines for the management of acute coronary syndromes Developed by the task force on …

always refer to the full text version, which is freely available on the ESC and EACTS
websites. The National Societies of the ESC are encouraged to endorse, translate, and …

These Guidelines represent the third time that the ESC and EACTS have brought together
cardiologists and cardiac surgeons in a joint Task Force to review the ever-increasing body …

Objectives: The aim of this study was to investigate the clinical outcomes of patients deferred
from coronary revascularization on the basis of instantaneous wave-free ratio (iFR) or …

The clinical value of fractional flow reserve and non-hyperaemic pressure ratios are well
established in determining an indication for percutaneous coronary intervention (PCI) in …

Objectives: The aims of the ERIS (Evolving Routine Standards of FFR Use) study are to
describe the current use of invasive coronary physiology assessment and discern the …

Coronary disease carries significant morbidity and mortality globally. The pandemic of
obesity and diabetes combined with an aging population have resulted in a significant …

Background Intracoronary physiology is increasingly used in nonculprit stenoses of patients
with acute coronary syndromes (ACS). However, evidence regarding the safety of fractional …

Objective We sought to evaluate the correlations of pre‐PCI QFR analysis with virtual PCI
called residual QFR and post‐PCI QFR compared to post‐PCI FFR. Background …